KR850001470B1 - 인돌 유도체의 제조 방법 - Google Patents

인돌 유도체의 제조 방법 Download PDF

Info

Publication number
KR850001470B1
KR850001470B1 KR1019810002197A KR810002197A KR850001470B1 KR 850001470 B1 KR850001470 B1 KR 850001470B1 KR 1019810002197 A KR1019810002197 A KR 1019810002197A KR 810002197 A KR810002197 A KR 810002197A KR 850001470 B1 KR850001470 B1 KR 850001470B1
Authority
KR
South Korea
Prior art keywords
methylbenzoic acid
acid
preparation
indole
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019810002197A
Other languages
English (en)
Korean (ko)
Other versions
KR830006205A (ko
Inventor
죤 애쉬턴 마이클
윌리암 브리지 앤드류
프레데릭 채프만 로버어트
펜톤 게리
하워드 러브레스 안토니
리델 데이빗드
Original Assignee
메이 앤드 베이커 리미팃드
다글라스 델림플 렘지 시벌드 20
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메이 앤드 베이커 리미팃드, 다글라스 델림플 렘지 시벌드 20 filed Critical 메이 앤드 베이커 리미팃드
Publication of KR830006205A publication Critical patent/KR830006205A/ko
Priority to KR1019850004259A priority Critical patent/KR850001550B1/ko
Priority to KR1019850004260A priority patent/KR850001549B1/ko
Application granted granted Critical
Publication of KR850001470B1 publication Critical patent/KR850001470B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019810002197A 1980-06-18 1981-06-16 인돌 유도체의 제조 방법 Expired KR850001470B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019850004259A KR850001550B1 (ko) 1980-06-18 1985-06-15 인돌 유도체의 제조방법
KR1019850004260A KR850001549B1 (ko) 1980-06-18 1985-06-15 인돌 유도체의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8019948 1980-06-18
GB19,948 1980-06-18

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1019850004259A Division KR850001550B1 (ko) 1980-06-18 1985-06-15 인돌 유도체의 제조방법
KR1019850004260A Division KR850001549B1 (ko) 1980-06-18 1985-06-15 인돌 유도체의 제조방법

Publications (2)

Publication Number Publication Date
KR830006205A KR830006205A (ko) 1983-09-20
KR850001470B1 true KR850001470B1 (ko) 1985-10-10

Family

ID=10514138

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810002197A Expired KR850001470B1 (ko) 1980-06-18 1981-06-16 인돌 유도체의 제조 방법

Country Status (22)

Country Link
US (1) US4493843A (enExample)
EP (1) EP0042298B1 (enExample)
JP (1) JPS5728048A (enExample)
KR (1) KR850001470B1 (enExample)
AT (1) ATE9329T1 (enExample)
AU (1) AU539678B2 (enExample)
CA (1) CA1149811A (enExample)
DE (1) DE3165998D1 (enExample)
DK (1) DK264281A (enExample)
ES (4) ES8300091A1 (enExample)
FI (1) FI811889A7 (enExample)
GB (1) GB2078736B (enExample)
GR (1) GR75701B (enExample)
HK (2) HK92684A (enExample)
HU (1) HU183480B (enExample)
IE (1) IE52102B1 (enExample)
IL (1) IL63110A (enExample)
MY (2) MY8500975A (enExample)
NZ (1) NZ197441A (enExample)
PH (1) PH16357A (enExample)
SG (2) SG68984G (enExample)
ZA (1) ZA814057B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
SK2612001A3 (en) * 1998-08-26 2001-11-06 Aventis Pharma Ltd Aza-bicycles which modulate the inhibition of cell adhesion
WO2001044184A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Synthesis of indole-containing spla2 inhibitors
AU2003247390A1 (en) 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc. Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
DE602005012380D1 (de) * 2004-03-15 2009-03-05 Lilly Co Eli 4-(5-(aminomethyl)-indol-1-ylmethyl)benzamidderivate und verwandte verbindungen als opioidrezeptorantagonisten zur behandlung von fettleibigkeit
JP6217561B2 (ja) * 2014-08-21 2017-10-25 信越化学工業株式会社 新規オニウム塩化合物及びレジスト組成物並びにパターン形成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076814A (en) * 1954-04-28 1963-02-05 Upjohn Co Novel process for the preparation of tryptophols and to novel compounds produced therein
DE2237361A1 (de) * 1972-07-29 1974-02-14 Boehringer Mannheim Gmbh (5-indolyloxy)-essigsaeure-derivate und verfahren zur herstellung derselben
US3992392A (en) * 1973-04-27 1976-11-16 The Ohio State University Research Foundation Synthesis of indoles from anilines and intermediates therein
US3901899A (en) * 1973-04-27 1975-08-26 Univ Ohio State Res Found Synthesis of indoles from anilines and intermediates therein
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
DE2909779A1 (de) * 1979-03-13 1980-09-18 Thomae Gmbh Dr K Neue indolderivate, deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
EP0042298A1 (en) 1981-12-23
IE52102B1 (en) 1987-06-24
FI811889L (fi) 1981-12-19
GB2078736A (en) 1982-01-13
IL63110A (en) 1986-10-31
ES8303333A1 (es) 1983-02-01
NZ197441A (en) 1984-11-09
ES8303332A1 (es) 1983-02-01
GB2078736B (en) 1984-03-07
ES503097A0 (es) 1982-10-01
ATE9329T1 (de) 1984-09-15
US4493843A (en) 1985-01-15
ES8305327A1 (es) 1983-04-01
HK92684A (en) 1984-11-30
HK92485A (en) 1985-11-29
ZA814057B (en) 1982-07-28
AU539678B2 (en) 1984-10-11
KR830006205A (ko) 1983-09-20
ES512705A0 (es) 1983-02-01
DE3165998D1 (de) 1984-10-18
PH16357A (en) 1983-09-05
FI811889A7 (fi) 1981-12-19
JPS5728048A (en) 1982-02-15
SG73085G (en) 1986-05-02
DK264281A (da) 1981-12-19
CA1149811A (en) 1983-07-12
AU7186481A (en) 1981-12-24
EP0042298B1 (en) 1984-09-12
SG68984G (en) 1985-03-15
ES8300091A1 (es) 1982-10-01
ES512704A0 (es) 1983-02-01
ES512706A0 (es) 1983-04-01
GR75701B (enExample) 1984-08-02
MY8500975A (en) 1985-12-31
MY8600409A (en) 1986-12-31
IE811344L (en) 1981-12-18
HU183480B (en) 1984-05-28

Similar Documents

Publication Publication Date Title
US4110351A (en) Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts
US4337263A (en) 1-Aryl-4-γ-arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use as hypolipemiant and hypocholesterolemiant agents
US3484445A (en) Derivatives of chromone-2-carboxylic acid
JPH0285246A (ja) ジ―ｔｅｒｔ―ブチルヒドロキシフェニルチオ誘導体
US4524149A (en) 5-Alkanoyl-6-alkyl-2(1H)-pyridinones, their preparation and their cardiotonic use
FR2540109A1 (fr) Imino-2 pyrrolidines, leur procede de preparation et leurs applications en therapeutique
US4412077A (en) Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
NO127149B (enExample)
DE602005002138T2 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung
US4278678A (en) Substituted oxy-cyclohexylacetic acid derivatives
US4163859A (en) Phenoxyldialkyl acetic acids and esters
EP0042298B1 (en) Indole and indoline derivatives
US4801591A (en) 2-alkenylene-thieno-1,2-thiazole derivatives with lipid-lowering activity
NO154840B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte 2-amino-3,4-dihydropyridinderivater.
KR840001034B1 (ko) 디하이드로니코틴산 유도체의 제조방법
US3308021A (en) Alkylamino quinoxalyl ethanols
US4103027A (en) Amino substituted arylthio-alkanoic acids having hypolipidemic activity
KR850001549B1 (ko) 인돌 유도체의 제조방법
US4833162A (en) Substituted benzeneacetonitriles and their use as calcium channel blockers
NO157214B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater.
LU82997A1 (fr) 6-(pyridinyl)-pyridazines,leur preparation et leur utilisation therapeutique
Kamal et al. 659. Hydroxy-carbonyl compounds. Part XIV. The syntheses of some iso coumarins
KR850001550B1 (ko) 인돌 유도체의 제조방법
US3801578A (en) 7-(2-hydroxy-3-(n-methyl-2-hydroxy-ethylamino)-propyl)-theophylline-2-(4-chlorophenoxy)-isobutyrate
LU85099A1 (fr) Isomere s du betaxolol,sa preparation et son application en therapeutique

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19901011

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19901011